SK&S and Loewen Advise on Velocity Clinical Research Acquisition of ClinMedica Research

SK&S and Loewen Advise on Velocity Clinical Research Acquisition of ClinMedica Research

Poland
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

SK&S Soltysinski Kawecki & Szlezak has advised Velocity Clinical Research on its acquisition of ClinMedica Research. Loewen Kaczmarek Zawadowski advised Deo Family Fundacja Rodzinna on the sale.

Velocity Clinical Research is a multi-specialty clinical sites business.

ClinMedica provides clinical research and specialized medical care services.

According to SK&S, "this acquisition of ClinMedica marks Velocity’s tenth site in Europe, in addition to its four sites in Germany and five in the UK. The new acquisition marks the start of Velocity’s expansion in Poland and is the first acquisition among the key ones planned by the company in Poland before the end of the year."

The SK&S  team included Partners Krzysztof Pawlisz, Piotr Andrzejak, Agnieszka Fedor, and Jacek Myszko, Senior Counsel Karol Skibniewski, Senior Associates Natalia Labeda and Tomasz Grabka, and Associates Magdalena Rozek, Piotr Mordzonek, Katarzyna Juralewicz, and Ewelina Woike-Regula.

The Loewen Kaczmarek Zawadowski team included Partners Artur Zawadowski and Szymon Kaczmarek and Trainee Advocate Klaudia Jedrzejczyk.